Allergiakeskus

Julkaisut 2019 (alustava)
Publications 2019 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Ahovuo-Saloranta A et al. Basic characteristics and clinical value of FeNO in smoking asthmatics-a systematic review.
2 Bousquet J et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.
3 Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.
4 Bousquet JJ et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.
5 Bulathsinhala L et al. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.
6 Csonka P, Lehtimäki L. Valved holding chamber drug delivery is dependent on breathing pattern and device design .
7 Csonka P, Lehtimäki L. In vitro drug delivery performance of five valved holding chambers with and without facemasks.
8 Csonka P, Lehtimäki L. Antistatic treatment and salbutamol dosing have variable effect on drug delivery of valved holding chambers.
9 Gracia-Tabuenca J et al. Tidal breathing flow profiles during sleep in wheezing children measured by impedance pneumography.
10 Honkamäki J et al. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood.
11 Karvonen T, Lehtimäki L. Flow-independent nitric oxide parameters in asthma: a systematic review and meta-analysis.
12 Kauppila T Kaisa et al. Outcome of oral immunotherapy for persistent cow's milk allergy from 11 years of experience in Finland.
13 Kivistö JE et al. Genetic and environmental susceptibility to food allergy in a registry of twins.
14 Koskela H et al. Epäsuorat altistuskokeet astman diagnosoinnissa.
15 Kotisalmi A et al. Aikuisiällä alkavan astman riskitekijät.
16 Kotisalmi E et al. Aikuisiässä alkavan astman riskitekijät.
17 Kujansuu E et al. Exposure to sewage water and the development of allergic manifestations in Finnish children.
18 Lampi et al. Parhaiten potilaan terveyttä suojellaan tutkitun tiedon pohjalta.
19 Lassmann-Klee PG et al. Converting FENO by different flows to standard flow FENO.
20 Lehtimäki L, Karjalainen J. Erikoissairaanhoidon rooli astman diagnostiikassa ja hoidossa.
21 Lehtimäki L, Moilanen E. Hengityselimistö ja sen tehtävät.
22 Lehtimäki L, Moilanen E. Hengityksen säätelyyn vaikuttavat lääkeaineet.
23 Lehtimäki L, Moilanen E. Astma ja keuhkoahtaumatauti.
24 Lehtimäki L, Moilanen E. Astman ja keuhkoahtaumataudin lääkehoidon yleiset periaatteet.
25 Lehtimäki L, Moilanen E. Inhalaatiolääkitys.
26 Lehtimäki L, Moilanen E. Hengitettävät glukokortikoidit.
27 Lehtimäki L, Moilanen E. Leukotrieenien estäjät.
28 Lehtimäki L, Moilanen E. IgE:n estäjät.
29 Lehtimäki L, Moilanen E. Interleukiini-5:n estäjät.
30 Lehtimäki L, Moilanen E. Teofylliini.
31 Lehtimäki L, Moilanen E. Fosfodiesteraasi-4:n estäjät.
32 Lehtimäki L, Moilanen E. Keuhkoputkien sileän lihaksen toiminta.
33 Lehtimäki L, Moilanen E. Keuhkoputkia laajentavat ß2-sympatomimeetit.
34 Lehtimäki L, Moilanen E. Antikolinergiset keuhkoputkia laajentavat lääkeaineet.
35 Lehtimäki L, Moilanen E. Pirfenidoni.
36 Lehtimäki L, Moilanen E. Nintedanibi.
37 Lehtimäki L, Moilanen E. Yskä ja yskänlääkkeet.
38 Lehtimäki L, Moilanen E. Opioidit yskänlääkkeenä.
39 Lehtimäki L, Moilanen E. Mukolyytit.
40 Lehtimäki L, Moilanen E. Hengitystieallergiat ja niiden hoitoperiaatteet.
41 Lehtimäki L, Moilanen E. Antihistamiinit.
42 Lehtimäki L, Moilanen E. Natriumkromoglikaatti ja nedokromiili.
43 Lehtimäki L, Moilanen E. Siedätyshoito allergeeneillä.
44 Levy ML et al. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
45 Lindström I et al. Altistuminen astmaa aiheuttaville tekijöille työssä. Suositus terveystarkistuksista.
46 Makkonen M, Korhonen N. Ihottumaa kylpytynnyristä.
47 Moilanen L et al. Transient Receptor Potential Ankyrin 1 Enhances Ovalbumin-Induced Acute Allergic Inflammation in Murine Models.
48 Nynäs P et al. Observational cross-sectional study on Symptoms Associated to Moisture DAmage at Workplace: the SAMDAW study protocol.
49 Oksa P et al. Trends in occupational diseases in Finland, 1975-2013 : a register study.
50 Protudjer JL et al. Epinephrine dispensings, allergy hospitalizations and the elimination of co-payments in Sweden.
51 Rannisto S et al. Correction of leg-length discrepancy among meat cutters with low back pain: a randomized controlled trial.
52 Rantala HA et al. Predictors of Impaired Survival in Subjects With Long-Term Oxygen Therapy.
53 Reho T et al. Frequent attenders in occupational health primary care: A cross-sectional study.
54 Rehottm et al. Occasional and persistent frequent attenders and sickness absences in occupational health primary care : a longitudinal study in Finland.
55 Seppä VP et al. Airway obstruction is associated with reduced variability in specific parts of tidal breathing flow-volume curve in young children.
56 Taponen S et al. Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
57 Tikkakoski AP et al. Association of air humidity with incidence of exercise-induced bronchoconstriction in children.
58 Tommola M et al. Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
59 Tommola M et al. Occupational exposures and asthma-COPD overlap in a clinical cohort of adult-onset asthma.
60 Toppila-Salmi S et al. Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age.
61 Tuomisto L et al. Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma.
62 Uusitalo A et al. Pelastustyöntekijän astma.

Julkaisutietokanta 31.12.2020 Publications Data Base 31.12.2020